119 related articles for article (PubMed ID: 28682833)
1. Cross-Platform Comparison of Computer-assisted Image Analysis Quantification of In Situ mRNA Hybridization in Investigative Pathology.
Holzer TR; Hanson JC; Wray EM; Bailey JA; Kennedy KR; Finnegan PR; Nasir A; Credille KM
Appl Immunohistochem Mol Morphol; 2019 Jan; 27(1):15-26. PubMed ID: 28682833
[TBL] [Abstract][Full Text] [Related]
2. Branched chain in situ hybridization for albumin as a marker of hepatocellular differentiation: evaluation of manual and automated in situ hybridization platforms.
Shahid M; Mubeen A; Tse J; Kakar S; Bateman AC; Borger D; Rivera MN; Ting DT; Deshpande V
Am J Surg Pathol; 2015 Jan; 39(1):25-34. PubMed ID: 25353287
[TBL] [Abstract][Full Text] [Related]
3. PTEN mRNA detection by chromogenic, RNA in situ technologies: a reliable alternative to PTEN immunohistochemistry.
Bingham V; Ong CW; James J; Maxwell P; Waugh D; Salto-Tellez M; McQuaid S
Hum Pathol; 2016 Jan; 47(1):95-103. PubMed ID: 26518664
[TBL] [Abstract][Full Text] [Related]
4. RNA chromogenic in situ hybridization assay with clinical automated platform is a sensitive method in detecting high-risk human papillomavirus in squamous cell carcinoma.
Mendez-Pena JE; Sadow PM; Nose V; Hoang MP
Hum Pathol; 2017 May; 63():184-189. PubMed ID: 28302536
[TBL] [Abstract][Full Text] [Related]
5. Estrogen Receptor-α Quantification in Breast Cancer: Concordance Between Immunohistochemical Assays and mRNA-In Situ Hybridization for ESR1 Gene.
Thomsen C; Nielsen S; Nielsen BS; Pedersen SH; Vyberg M
Appl Immunohistochem Mol Morphol; 2020; 28(5):347-353. PubMed ID: 30920963
[TBL] [Abstract][Full Text] [Related]
6. Performance of a Branch Chain RNA In Situ Hybridization Assay for the Detection of High-risk Human Papillomavirus in Head and Neck Squamous Cell Carcinoma.
Kerr DA; Arora KS; Mahadevan KK; Hornick JL; Krane JF; Rivera MN; Ting DT; Deshpande V; Faquin WC
Am J Surg Pathol; 2015 Dec; 39(12):1643-52. PubMed ID: 26426378
[TBL] [Abstract][Full Text] [Related]
7. Concordance levels of PD-L1 expression by immunohistochemistry, mRNA in situ hybridization, and outcome in lung carcinomas.
Coppock JD; Volaric AK; Mills AM; Gru AA
Hum Pathol; 2018 Dec; 82():282-288. PubMed ID: 30075155
[TBL] [Abstract][Full Text] [Related]
8. A Multi-Institutional Study to Evaluate Automated Whole Slide Scoring of Immunohistochemistry for Assessment of Programmed Death-Ligand 1 (PD-L1) Expression in Non-Small Cell Lung Cancer.
Taylor CR; Jadhav AP; Gholap A; Kamble G; Huang J; Gown A; Doshi I; Rimm DL
Appl Immunohistochem Mol Morphol; 2019 Apr; 27(4):263-269. PubMed ID: 30640753
[TBL] [Abstract][Full Text] [Related]
9. fISHing with immunohistochemistry for housekeeping gene changes in Alzheimer's disease using an automated quantitative analysis workflow.
Highet B; Vikas Anekal P; Ryan B; Murray H; Coppieters N; Victor Dieriks B; Singh-Bains MK; Mehrabi NF; Faull RLM; Dragunow M; Curtis MA
J Neurochem; 2021 May; 157(4):1270-1283. PubMed ID: 33368239
[TBL] [Abstract][Full Text] [Related]
10. Overcoming Autofluorescence (AF) and Tissue Variation in Image Analysis of In Situ Hybridization.
Brodie C
Methods Mol Biol; 2020; 2148():19-32. PubMed ID: 32394373
[TBL] [Abstract][Full Text] [Related]
11. High-risk human papillomavirus E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma.
Ukpo OC; Flanagan JJ; Ma XJ; Luo Y; Thorstad WL; Lewis JS
Am J Surg Pathol; 2011 Sep; 35(9):1343-50. PubMed ID: 21836494
[TBL] [Abstract][Full Text] [Related]
12. RNA In Situ Hybridization for Epstein-Barr Virus and Cytomegalovirus: Comparison With In Situ Hybridization and Immunohistochemistry.
Roe CJ; Siddiqui MT; Lawson D; Cohen C
Appl Immunohistochem Mol Morphol; 2019 Feb; 27(2):155-159. PubMed ID: 28800011
[TBL] [Abstract][Full Text] [Related]
13. Quantitative comparison and reproducibility of pathologist scoring and digital image analysis of estrogen receptor β2 immunohistochemistry in prostate cancer.
Rizzardi AE; Zhang X; Vogel RI; Kolb S; Geybels MS; Leung YK; Henriksen JC; Ho SM; Kwak J; Stanford JL; Schmechel SC
Diagn Pathol; 2016 Jul; 11(1):63. PubMed ID: 27401406
[TBL] [Abstract][Full Text] [Related]
14. Peptidylpropyl isomerase B (PPIB): a suitable reference gene for mRNA quantification in peripheral whole blood.
Pachot A; Blond JL; Mougin B; Miossec P
J Biotechnol; 2004 Oct; 114(1-2):121-4. PubMed ID: 15464605
[TBL] [Abstract][Full Text] [Related]
15. Computer-Based Intensity Measurement Assists Pathologists in Scoring Phosphatase and Tensin Homolog Immunohistochemistry - Clinical Associations in NSCLC Patients of the European Thoracic Oncology Platform Lungscape Cohort.
Rulle U; Tsourti Z; Casanova R; Deml KF; Verbeken E; Thunnissen E; Warth A; Cheney R; Sejda A; Speel EJ; Madsen LB; Nonaka D; Navarro A; Sansano I; Marchetti A; Finn SP; Monkhorst K; Kerr KM; Haberecker M; Wu C; Zygoura P; Kammler R; Geiger T; Gendreau S; Schulze K; Vrugt B; Wild P; Moch H; Weder W; Ciftlik AT; Dafni U; Peters S; Bubendorf L; Stahel RA; Soltermann A
J Thorac Oncol; 2018 Dec; 13(12):1851-1863. PubMed ID: 30240851
[TBL] [Abstract][Full Text] [Related]
16. Free digital image analysis software helps to resolve equivocal scores in HER2 immunohistochemistry.
Helin HO; Tuominen VJ; Ylinen O; Helin HJ; Isola J
Virchows Arch; 2016 Feb; 468(2):191-8. PubMed ID: 26493985
[TBL] [Abstract][Full Text] [Related]
17. Computer-aided detection (CAD) and assessment of malignant lesions in the liver and lung using a novel PET/CT software tool: initial results.
Hahn S; Heusner T; Zhou X; Zhan Y; Peng Z; Hamami M; Forsting M; Bockisch A; Antoch G
Rofo; 2010 Mar; 182(3):243-7. PubMed ID: 19859858
[TBL] [Abstract][Full Text] [Related]
18. Validation of nonradioactive in situ hybridization as a quantitative approach of messenger ribonucleic acid variations: a comparison with northern blot.
Guiot Y; Rahier J
Diagn Mol Pathol; 1997 Oct; 6(5):261-6. PubMed ID: 9458384
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus (EBV)-encoded RNA: automated in-situ hybridization (ISH) compared with manual ISH and immunohistochemistry for detection of EBV in pediatric lymphoproliferative disorders.
Fanaian NK; Cohen C; Waldrop S; Wang J; Shehata BM
Pediatr Dev Pathol; 2009; 12(3):195-9. PubMed ID: 18442302
[TBL] [Abstract][Full Text] [Related]
20. Validation of tumor protein marker quantification by two independent automated immunofluorescence image analysis platforms.
Peck AR; Girondo MA; Liu C; Kovatich AJ; Hooke JA; Shriver CD; Hu H; Mitchell EP; Freydin B; Hyslop T; Chervoneva I; Rui H
Mod Pathol; 2016 Oct; 29(10):1143-54. PubMed ID: 27312066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
